Abstract

The associations between anxiety disorders and substance use disorders (SUDs) have received significant attention in recent years. This is apt both because of the growing literature suggesting the presence of comorbidity and possible causal and functional linkages across these disorders, and this attention is encouraged by clinical demand for treatment options for these patients. Indeed, the comorbidity of these conditions creates a wealth of challenges for practitioners. According to McGovern, Xie, Segal, Siembab, and Drake (2006) “when it comes to providing services to persons with co-occurring disorders, addiction treatment providers may find themselves lost between the vague and the overly particular. This makes research-to-practice translations even more difficult than usual” (p. 267).